Evidence map›Paper›PMID 33304622›Full record

ArticleCurrent health sciences journal

Analysis of Tumour Related Data and Clinical Features of Eyelid Carcinomas.

Irina-Maria MercuŢ, Louis-Claudiu Ilia, Cornelia-Andreea TĂnasie, Mihaela Ionescu, Razvan MercuŢ, Vlad PÎrvĂnescu, Marius-Eugen Ciurea

Open access · greenAbstract read
In one paragraph

Article in Current health sciences journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Squamous cell carcinoma of the eyelid.Japanese journal of clinical oncology · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Irina-Maria MercuŢDepartment of Ophthalmology, University of Medicine and Pharmacy of Craiova, Romania.
Louis-Claudiu IliaDepartment of Ophthalmology, University of Medicine and Pharmacy of Craiova, Romania.
Cornelia-Andreea TĂnasieDepartment of Ophthalmology, University of Medicine and Pharmacy of Craiova, Romania.
Mihaela IonescuDepartment of Bioinformatics and Biostatistics, University of Medicine and Pharmacy of Craiova, Romania.
Razvan MercuŢDepartment of Plastic Surgery, University of Medicine and Pharmacy of Craiova, Romania.
Vlad PÎrvĂnescuDepartment of Plastic Surgery, University of Medicine and Pharmacy of Craiova, Romania.
Marius-Eugen CiureaDepartment of Plastic Surgery, University of Medicine and Pharmacy of Craiova, Romania.
University of Medicine and Pharmacy of Craiova · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Almost 10% of worldwide skin cancers are located at the eyelid level. In European countries, malign eyelid tumours are mostly represented by basal and squamous cell carcinomas, and usually affect elderly patients. In order to study the clinical features of eyelid tumours, and potential correlations between tumour parameters, we have enrolled a cohort of 98 subjects from a south-western region of Romania. Our study confirmed the majority of results from other European studies, as basal cell carcinoma was the most frequent malign form, being diagnosed for more than 85% of patients with declared prolonged sun exposure; tumours were mostly located on the superior eyelid, especially for males, and may present slow progression rates. We have identified significant correlations only between the tumour stage and symptoms' duration, and also between the tumour stage and smoking habit, for females.

Indexed as

basal cell carcinomaEyelid tumourskin cancersquamous cell carcinoma

Identifiers

PMID33304622
PMCPMC7716762
OpenAlexW3112055389

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.